{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04314375",
            "orgStudyIdInfo": {
                "id": "BUUC4991"
            },
            "organization": {
                "fullName": "Bausch Health Americas, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis",
            "officialTitle": "A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets n Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis",
            "therapeuticArea": [
                "Gastroenterology"
            ],
            "study": "study-to-evaluate-the-safety-efficacy-and-pharmacokinetics-of-budesonide-extended-release-tablets-in-pediatric-subjects-aged-to-years-with-active-mild-to-moderate-ulcerative-colitis"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-10",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-09-29",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-03-17",
            "studyFirstSubmitQcDate": "2020-03-17",
            "studyFirstPostDateStruct": {
                "date": "2020-03-19",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-10-05",
            "lastUpdatePostDateStruct": {
                "date": "2023-10-10",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Bausch Health Americas, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a randomized, double-blind, placebo-controlled, multicenter, study to evaluate the efficacy, safety, and pharmacokinetics (PK) of budesonide extended-release tablets for the induction of remission in pediatric subjects, with active, mild to moderate ulcerative colitis (UC). Subjects will be permitted to continue taking background oral or rectal 5-aminosalicylate (5-ASA) products."
        },
        "conditionsModule": {
            "conditions": [
                "Ulcerative Colitis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 70,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Low Dose Budesonide",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Low Dose Budesonide"
                    ]
                },
                {
                    "label": "High Dose Budesonide",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: High Dose Budesonide"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Low Dose Budesonide",
                    "description": "3 milligrams once daily for ages 5 to 11 years 11 months. 6 milligrams once daily for ages 12 to 17 years.",
                    "armGroupLabels": [
                        "Low Dose Budesonide"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "High Dose Budesonide",
                    "description": "6 milligrams once daily for ages 5 to 11 years 11 months. 9 milligrams once daily for ages 12 to 17 years.",
                    "armGroupLabels": [
                        "High Dose Budesonide"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Matching placebo once daily.",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "The primary efficacy endpoint is the proportion of subjects who achieve clinical remission at Day 56, defined as a total Mayo score of \u2264 1 with subscores of 0 for both rectal bleeding and stool frequency, and a subscore of \u2264 1 for endoscopy.",
                    "description": "The primary efficacy endpoint is the proportion of subjects who achieve clinical remission at Day 56, defined as a total Mayo score of \u2264 1 with subscores of 0 for both rectal bleeding and stool frequency, and a subscore of \u2264 1 for endoscopy. The Mayo score is a composite index score based on 4 components: stool frequency (subject reported), rectal bleeding (subject reported), findings of endoscopy, and the physician's rating of disease activity. Each component is scored from 0 to 3, with total scores range from 0 to 12 with higher scores indicating more severe disease.",
                    "timeFrame": "56 days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Proportion of subjects who achieve a Mayo rectal bleeding subscale score of 0 at Day 56.",
                    "description": "Proportion of subjects who achieve a Mayo rectal bleeding subscale score of 0 at Day 56. The Mayo score is a composite index score based on 4 components: stool frequency (subject reported), rectal bleeding (subject reported), findings of endoscopy, and the physician's rating of disease activity. Each component is scored from 0 to 3, with total scores range from 0 to 12 with higher scores indicating more severe disease.",
                    "timeFrame": "56 days"
                },
                {
                    "measure": "Proportion of subjects who achieve a Mayo stool frequency subscale score of 0 at Day 56.",
                    "description": "Proportion of subjects who achieve a Mayo stool frequency subscale score of 0 at Day 56. The Mayo score is a composite index score based on 4 components: stool frequency (subject reported), rectal bleeding (subject reported), findings of endoscopy, and the physician's rating of disease activity. Each component is scored from 0 to 3, with total scores range from 0 to 12 with higher scores indicating more severe disease.",
                    "timeFrame": "56 days"
                },
                {
                    "measure": "Proportion of subjects who achieve a Mayo endoscopy subscale score of 0 or 1 at Day 56.",
                    "description": "Proportion of subjects who achieve a Mayo endoscopy subscale score of 0 or 1 at Day 56. The Mayo score is a composite index score based on 4 components: stool frequency (subject reported), rectal bleeding (subject reported), findings of endoscopy, and the physician's rating of disease activity. Each component is scored from 0 to 3, with total scores range from 0 to 12 with higher scores indicating more severe disease.",
                    "timeFrame": "56 days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Established diagnosis of UC is based on:\n\n  * Clinical history\n  * Characteristic endoscopic findings\n  * Histopathology results from biopsies\n* Age 5 to 17 years, inclusive, at Screening. Subjects should weigh greater than 13.6 kg at Baseline.\n* Active UC of mild or moderate severity, defined as a total Mayo score between 4 and 10, inclusive, with rectal bleeding subscore of \u2265 1, stool frequency subscore of \u22651 and an endoscopy subscore of \u2265 1.\n* If on a background oral or rectal 5-ASA, the dose and formulation have remained unchanged for at least 6 weeks prior to Visit 2 (randomization), Baseline and the subject is willing to remain on the same formulation and dose for the duration of the study.\n\nExclusion Criteria:\n\n1. Current or prior diagnosis of Crohn's disease or indeterminate colitis.\n2. Limited distal proctitis (disease involving only the first 15 centimeters or less proximal to the anal verge.\n3. Severe UC, defined as total Mayo score \\>10.\n4. Not currently in an active phase or flare, defined as a total Mayo score \\<4, or Mayo score between 4 and 10, but Mayo subscore of 0 for rectal bleeding, stool frequency or endoscopy.\n5. Infectious colitis (based on positive microbiologic tests at Screening) or any recent history of infectious colitis (within 30 days prior to Screening).\n6. Prior gastrointestinal surgery, except appendectomy or hernia (e.g., inguinal, umbilical).\n\n   NOTE: Prior cholecystectomy is not exclusionary if more than 1 year prior to Screening.\n7. Evidence or history of toxic megacolon or bowel resection.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "5 Years",
            "maximumAge": "17 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Sandra Narain",
                    "role": "CONTACT",
                    "phone": "9082428287",
                    "email": "sandra.narain@bauschhealth.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Varsha Bhatt",
                    "affiliation": "Bausch Health",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Bausch Health Site 008",
                    "status": "RECRUITING",
                    "city": "Garden Grove",
                    "state": "California",
                    "zip": "92845",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.77391,
                        "lon": -117.94145
                    }
                },
                {
                    "facility": "Bausch Health Site 003",
                    "status": "RECRUITING",
                    "city": "Indianapolis",
                    "state": "Indiana",
                    "zip": "46202",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.76838,
                        "lon": -86.15804
                    }
                },
                {
                    "facility": "Bausch Health Site 006",
                    "status": "RECRUITING",
                    "city": "Bronx",
                    "state": "New York",
                    "zip": "10467",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.84985,
                        "lon": -73.86641
                    }
                },
                {
                    "facility": "Bausch Health Site 010",
                    "status": "RECRUITING",
                    "city": "Greenville",
                    "state": "North Carolina",
                    "zip": "27834",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.61266,
                        "lon": -77.36635
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003092",
                    "term": "Colitis"
                },
                {
                    "id": "D000003093",
                    "term": "Colitis, Ulcerative"
                },
                {
                    "id": "D000014456",
                    "term": "Ulcer"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005759",
                    "term": "Gastroenteritis"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000003108",
                    "term": "Colonic Diseases"
                },
                {
                    "id": "D000007410",
                    "term": "Intestinal Diseases"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000015212",
                    "term": "Inflammatory Bowel Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M17206",
                    "name": "Ulcer",
                    "asFound": "Ulcerative",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6320",
                    "name": "Colitis",
                    "asFound": "Colitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6321",
                    "name": "Colitis, Ulcerative",
                    "asFound": "Ulcerative Colitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8875",
                    "name": "Gastroenteritis",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6336",
                    "name": "Colonic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10444",
                    "name": "Intestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17917",
                    "name": "Inflammatory Bowel Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000019819",
                    "term": "Budesonide"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000001993",
                    "term": "Bronchodilator Agents"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018927",
                    "term": "Anti-Asthmatic Agents"
                },
                {
                    "id": "D000019141",
                    "term": "Respiratory System Agents"
                },
                {
                    "id": "D000005938",
                    "term": "Glucocorticoids"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21711",
                    "name": "Budesonide",
                    "asFound": "Foot",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M5269",
                    "name": "Bronchodilator Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20963",
                    "name": "Anti-Asthmatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M21137",
                    "name": "Respiratory System Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9047",
                    "name": "Glucocorticoids",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}